CAS: 23761-23-1; 3-Oxocyclobutanecarboxylic Acid

相似化合物

145549-76-4 695-95-4 87121-89-9

上下游产品

CAS号115118-68-8 3,3-二甲氧基环丁烷-1,1... | CAS号15760-36-8 3-亚甲基环丁烷羧酸 | CAS号115118-67-7 diethyl 3,3-dim... | CAS号15760-35-7 3-亚甲基环丁基甲腈 | CAS号480449-99-8 3-羟基环丁基甲酸苄酯 | CAS号4934-99-0 3-羟基环丁烷羧酸甲酯 | CAS号23761-24-2 3-溴环丁烷酮 | CAS号87121-89-9 3-氧代环丁烷羧酸乙酯 | CAS号935273-86-2 3,3-二氟环丁烷甲酸苄酯 | CAS号695-95-4 3-羰基-环丁烷甲酸甲酯 | CAS号100050-26-8 Cyclobutanecarb... | CAS号145549-76-4 3-氧代环丁基羧酸叔丁酯 | CAS号107496-54-8 3,3-二氟环丁烷羧酸 | CAS号154748-63-7 N-B°C-3-氨基环丁醇

3-亚甲基环丁基甲腈置于potassium Osmate(Vi) Dihydrate,Sodium Periodate,水,Potassium Hydroxide体系中,用 四氢呋喃,乙醇,水 用作溶剂,化学反应 2.0H,反应生成3-氧代环丁烷基羧酸
参考文献: Cyclic Amine Substituted Oxazolidinone Cetp Inhibitor[fr] Inhibiteur De Cetp Substitué Par Des Amines Cycliques à Base D'Oxazolidinone
标题: Cyclic Amine Substituted Oxazolidinone Cetp Inhibitor[fr] Inhibiteur De Cetp Substitué Par Des Amines Cycliques à Base D'Oxazolidinone
摘要:具有公式i结构的化合物,包括这些化合物的药用盐,是cetp抑制剂,可用于提高hdl胆固醇,降低ldl胆固醇,并用于治疗或预防动脉粥样硬化.在公式i的化合物中,A3是一个取代苯基或茚基.公式(i).

专利信息

专利号:WO-2024064745-A1
优先权日:2022-09-21
标 题:Synthesis of reldesemtiv
发明人：PETERSON MATTHEW W; LU QING; MORGAN BRADLEY P; ASHCRAFT LUKE W; ANDERSEN DENISE
权利人:CYTOKINETICS INC
摘要:Provided herein is a process for the preparation of reldesemtiv and salts thereof. Also provided herein are intermediates used in this process and their preparation.

专利号:WO-2025003177-A1
优先权日:2023-06-27
标题:Benzyl (3-(methyl(7h-pyrrolo[2,3-d]pyrimidin-4yl)amino)cyclobutyl) carbamate or a salt thereof, method for the preparation thereof, and use thereof in the synthesis of abrocitinib

专利号:WO-2023250107-A1
优先权日:2022-06-23
标 题 :Process for preparing modulators of eukaryotic initiation factor 2b
发明人：BRAK KATRIEN; HALE CHRISTOPHER; SUDHAKAR ANANTHA
权利人:DENALI THERAPEUTICS INC
摘要:The present disclosure relates generally to methods for the preparation of Compound (I-1): I-1 or a stereoisomer or mixture of stereoisomers thereof, or salt of each thereof, as well as compounds and salts which are useful in the synthesis thereof.

专利号:CN-114163323-B
优先权日:2021-12-13
标题 :A kind of synthesis method of 3-oxocyclobutanecarboxylic acid

专利号:US-8445510-B2
优先权日:2010-05-14
标题 :Fused bicyclic kinase inhibitors
发明人：MULVIHILL MARK J; STEINIG ARNO G; CREW ANDREW PHILIP; JIN MEIZHONG; KLEINBERG ANDREW; LI AN-HU; WANG JING
权利人:MULVIHILL MARK J; STEINIG ARNO G; CREW ANDREW PHILIP; JIN MEIZHONG; KLEINBERG ANDREW; LI AN-HU; WANG JING; OSI PHARMACEUTICALS LLC
摘要:Compounds of Formula I, as shown below and defined herein: n n n n n n n n n n pharmaceutically acceptable salts thereof, synthesis, intermediates, formulations, and methods of disease treatment therewith, including treatment of cancers, such as tumors driven at least in part by at least one of RON, MET or ALK. This Abstract is not limiting of the invention.

专利号:US-9096624-B2
优先权日:2009-06-01
标 题:Amino pyrimidine anticancer compounds
发明人：CREW ANDREW P; SHERMAN DAN; APPARI RAMA DEVI; CHEN XIN; CHILUKURI RAMESH; DONG HANQING; FERRARO CATERINA; FOREMAN KENNETH; GUPTA RAMESH C; LI AN-HU; STOLZ KATHRYN M; VOLK BRIAN; ZAHLER ROBERT
权利人:OSI PHARMACEUTICALS LLC
摘要:Compounds of Formula 1, as shown below and defined herein: n n n n n n n n n n n n and pharmaceutically acceptable salts, synthesis, intermediates, formulations, and methods of disease treatment therewith, including cancers mediated at least in part by FAK.